Increased prevalence of primary hyperparathyroidism in treated breast cancer

被引:34
|
作者
Fierabracci, P
Pinchera, A
Miccoli, P
Conte, PF
Vignali, E
Zaccagnini, M
Marcocci, C
Giani, C
机构
[1] Univ Pisa, Dipartimento Endocrinol & Metab, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Surg, I-56124 Pisa, Italy
[3] Univ Pisa, Dept Oncol, I-56124 Pisa, Italy
关键词
breast cancer; hyperparathyroidism; parathyroid adenoma; PTH; calcium;
D O I
10.1007/BF03343867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercalcemia occurring in patients with advanced breast cancer (BC) is generally due to osteolytic metastases or to the activity of circulating tumor-derived products. In these conditions, the production of endogenous PTH is reduced. The frequency of hypercalcemia due to primary hyperparathyroidism in breast cancer is unknown. We examined the occurrence of primary hyperparathyroidism in a large group of women with treated BC. A total of 100 consecutive women aged 28-80 years with treated breast cancer were enrolled. One hundred and two healthy age-matched women and 60 age-matched female patients with differentiated thyroid carcinoma examined before thyroidectomy were used as controls. Intact serum PTH and serum calcium were measured in all patients and controls. Hypercalcemia associated with elevated serum PTH concentration indicating primary hyperparathyroidism was found in 7 BC patients (7%) and in none of healthy women or patients with thyroid cancer. The pre-operative staging of BC patients with primary hyperparathyroidism was I in six and II in one of them, and no patient had evidence of distant metastases. A parathyroid adenoma was found in all 6 BC patients submitted to neck exploration, one patient refused surgery. Serum calcium and PTH concentrations returned to normal levels after surgery. Two BC patients had increased serum PTH and normal calcium concentrations. One of them had low serum 25-hydroxyvitamin D [25(OH)D]. One patient with spread bone metastases had neoplastic hypercalcemia with undetectable serum PTH concentration. All remaining 90 BC patients had serum calcium and PTH concentrations within normal limits, but their mean (+/- SD) values (9.6 +/-0.5 mg/dl for serum calcium, 38.0 +/- 16.4 mg/dl for serum PTH) were slightly but significantly greater than in normal controls (9.3 +/-0.5 mg/dl, p=0.003 and 27.9 +/- 10.6 pg/ml, p=0.0001, respectively) and in patients with thyroid cancer (9.2 +/-0.6 mg/dl, p=0.001 and 26.2 +/- 11.0 pg/ml, p=0.001), with no relationship with clinical staging or anti-tumor therapy. In conclusion: 1) an increased frequency of parathyroid adenoma was found in BC patients with mildly aggressive neoplastic disease; 2) in BC patients with no evidence of primary hyperparathyroidism mean serum PTH and calcium concentrations were significantly greater than in healthy controls and in patients with thyroid carcinoma; and 3) this finding was unrelated to clinical staging or anti-tumor therapy. Thus, primary hyperparathyroidism should be considered as a possible cause of hypercalcemia in patients with non-aggressive breast cancer. We suggest that serum PTH should be determined in all BC patients with increased serum calcium concentration, especially in those with no evidence of metastatic disease.
引用
收藏
页码:315 / 320
页数:6
相关论文
共 50 条
  • [31] PREVALENCE OF CHONDROCALCINOSIS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM IN JAPAN
    YASHIRO, T
    OKAMOTO, T
    TANAKA, R
    ITO, K
    HARA, H
    YAMASHITA, T
    KANAJI, Y
    KODAMA, T
    ITO, Y
    OBARA, T
    FUJIMOTO, Y
    ENDOCRINOLOGIA JAPONICA, 1991, 38 (05): : 457 - 464
  • [32] Prevalence and characteristics of metabolic syndrome in primary hyperparathyroidism
    F. Tassone
    L. Gianotti
    C. Baffoni
    F. Cesario
    G. Magro
    M. Pellegrino
    I. Emmolo
    M. Maccario
    G. Borretta
    Journal of Endocrinological Investigation, 2012, 35 : 841 - 846
  • [33] Prevalence of Helicobacter pylori in patients with primary hyperparathyroidism
    Hatice Sebila Dökmetaş
    Cansel Türkay
    Cengiz Aydin
    Sema Arici
    Journal of Bone and Mineral Metabolism, 2001, 19 : 373 - 377
  • [34] Increased prevalence of breast cancer in female patients with lichen sclerosus
    Li, Xiaoxiao
    Dooley, Sean W.
    Patton, Timothy J.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (01) : 178 - 180
  • [35] IS THE PREVALENCE OF RECTOSIGMOID ADENOMAS INCREASED IN THE CASE OF BREAST-CANCER
    JOUIN, H
    DERLON, A
    VARRA, A
    BAUMANN, R
    CALDEROLI, H
    JAECK, D
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1987, 11 (2BIS): : A222 - A222
  • [36] Increased Breast Cancer Prevalence Among Female Orthopedic Surgeons
    Chou, Loretta B.
    Chandran, Sheena
    Harris, Alex H. S.
    Tung, Joanna
    Butler, Lesley M.
    JOURNAL OF WOMENS HEALTH, 2012, 21 (06) : 683 - 689
  • [37] Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism
    Run Yu
    Endocrine, 2016, 53 : 868 - 869
  • [38] Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism
    Yu, Run
    ENDOCRINE, 2016, 53 (03) : 868 - 869
  • [39] Hypercalcemia due to Co-Occurring Metastatic Breast Cancer and Primary Hyperparathyroidism
    Khubaib, Mohammad U.
    Fadlalla, Rania
    Ahmad, Javaria
    Naseer, Zainab
    Mhanna, Hussein
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [40] Challenges of Differential Diagnosis Between Primary Hyperparathyroidism and Bone Metastases of Breast Cancer
    Gorobeiko, Maksym
    Dinets, Andrii
    Pominchuk, Denys
    Abdalla, Karim
    Prylutskyy, Yuriy
    Hoperia, Viktoria
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2022, 15